Organon & Co | Netto Inntekt



Net Income Endring Dato
Adcock Ingram Holdings ZAR 369.84M 74.33M 2024-06
Bristol-Myers Squibb USD 72M 1.14B 2024-12
Celltrion KRW 85.59B 7.58B 2024-09
Cspc Pharmaceutical CNY 757.66M 649.86M 2024-09
Dianthus Therapeutics USD -28440000 3.27M 2024-12
Ecofibre AUD 617K 46.2M 2024-06
Gilead Sciences USD 1.78B 529M 2024-12
Glaxosmithkline GBP 414M 472M 2024-12
Kangmei Pharma CNY -10744790 19.03M 2024-09
Knight Therapeutics CAD 85K 2.03M 2024-09
Laboratorios Farma EUR 92.54M 63.16M 2024-12
Malin Corporation EUR 0 1.1M 2024-06
Medical Developments International AUD -15020000 4.08M 2024-06
Merck USD 3.74B 586M 2024-12
Neuren Pharmaceuticals AUD 134.03M 126.01M 2024-12
Novartis USD 2.82B 371M 2024-12
Organigram Holdings CAD -22957000 17.52M 2024-12
Organon & Co USD 109M 250M 2024-12
Pharma Mar EUR 18.68M 14.78M 2024-12
Qiagen NV USD 88.32M 9.74M 2024-12
Sartorius EUR 48.4M 4M 2025-03
Sino Biopharmaceutical CNY 482.67M 1.03B 2024-12
Tilray USD -85342000 46.18M 2024-11



Organon & Co Netto Inntekt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.